If the trial NOX66-002A (most recently open for recruitment), sends irradiated lesions into remission, then that supports the need for further investigation on a larger scale. The share price should respond accordingly because this seems to far exceed any current standard treatment outcomes.
If however the trial achieves an abscopal response or two, then this will surely send a pretty strong ultimatum to anyone considering buying into the company.
I also note today marked the twelfth straight Monday in which the closing price eclipsed that of the previous Friday.
If the trial NOX66-002A (most recently open for recruitment),...
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 33843 | 2 |
View Market Depth
| Last trade - 10.36am 08/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable